Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/21/23 16:02 | 2/16/23 | ACON | Health | Health | Medical Laboratories | Thramann Jeffrey John | CO | DO | Exec CB | P | 1 | 1,000.0 | 0 | 0 | New | 0 | D | ||||||||||||||
12/29/22 19:57 | 12/28/22 | ACON | Health | Health | Medical Laboratories | Ness Brent | CO | DO | CEO | P.m | 10 | 0.5280 | 0 | 19 | 999% | 20 | D | ||||||||||||||
12/29/22 18:27 | 12/29/22 | ACON | Health | Health | Medical Laboratories | Lorbiecki John Paul | CO | O | CFO | P | 10 | 0.4463 | 0 | 22 | 22 | D | |||||||||||||||
4/25/22 17:28 | 4/22/22 | ACON | Health | Health | Medical Laboratories | Bond Ryan | CA | O | Chief St | P.d | 56 | 2.80 | 0 | 20 | New | 20 | D | ||||||||||||||
4/25/22 17:27 | 4/21/22 | ACON | Health | Health | Medical Laboratories | Wesemann William | CA | D | P.d | 48 | 4.35 | 0 | 11 | 26 | 53 | D | |||||||||||||||
4/25/22 17:26 | 4/21/22 | ACON | Health | Health | Medical Laboratories | Ness Brent | CA | DO | CEO | P.d | 4 | 4.35 | 0 | 1 | New | 1 | D | ||||||||||||||
4/25/22 17:26 | 4/21/22 | ACON | Health | Health | Medical Laboratories | Neal David K | CA | D | P.d | 150 | 4.35 | 0 | 34 | New | 34 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |